Sabrina Paganoni, MD, PhD of Massachusetts General Hospital was joined by Jinsy Andrews, MD, MSc, FAAN, FANA of Columbia University to discuss news and updates about Expanded Access in the field of ALS research. Dr. Andrews provided an overview about Expanded Access, outlined plans for Clene's upcoming NIH-funded EAP for CNM-Au8 (the investigational product studied in Regimen C of the HEALEY ALS Platform Trial), and answered questions from the audience.

Visit the Mass General website to register for future webinars: https://www.massgeneral.org/neurology...

Sign up for the ALS Link to stay up to date about the Platform Trial and ALS research: https://lp.constantcontactpages.com/s...

Follow MGH Neurology on Facebook (  / mghneurology  ) and Twitter (  / mghneurology  )